COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN
Objectives: to assess the practical clinical value of comorbidities in psoriasis and psoriatic arthritis. Material and methods. A group of 92 patients, with psoriatic arthritis, established in accordance with the CASPAR diagnostic criteria (2006) was selected with a prospective study with retrospective components. The average age of patients with psoriatic arthritis was 42.9±9.6 years, the average duration of psoriasis was 11 (7; 25.8) years, the average duration of psoriatic arthritis was 7 (2; 11.8) years. Among the patients included in the study were 42 (45.7%) men and 50 (54.3%) women. Results. The most common pathology was hypertension with a frequency of 38%, exertional angina – in 5.4% and postinfarct cardiosclerosis – in 2.2%, chronic heart failure – in 6.5% of patients. Cardiovascular pathology combined with diabetes mellitus, dyslipidemia, etc., was observed in 16.3% of patients. Cerebrovascular disorders were detected in 3.3%. Conclusions. A holistic approach to patients with PsA and Ps is recommended – focusing not only on skin or joint symptoms, but also on all aspects of the disease, including comorbidities, can improve the management of the disease and prevent long-term mental and physical impairment..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
---|---|
Enthalten in: |
Arta Medica - 89(2023), 4 |
Sprache: |
Englisch ; Rumänisch ; Russisch |
---|
Beteiligte Personen: |
Lucia Dutca [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Clinician's guidelines |
---|
doi: |
10.5281/zenodo.10429309 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ098143972 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ098143972 | ||
003 | DE-627 | ||
005 | 20240413205126.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5281/zenodo.10429309 |2 doi | |
035 | |a (DE-627)DOAJ098143972 | ||
035 | |a (DE-599)DOAJ82ef7dcc2bd0444b92dc14204665084c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a rum |a rus | ||
050 | 0 | |a RD1-811 | |
100 | 0 | |a Lucia Dutca |e verfasserin |4 aut | |
245 | 1 | 0 | |a COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Objectives: to assess the practical clinical value of comorbidities in psoriasis and psoriatic arthritis. Material and methods. A group of 92 patients, with psoriatic arthritis, established in accordance with the CASPAR diagnostic criteria (2006) was selected with a prospective study with retrospective components. The average age of patients with psoriatic arthritis was 42.9±9.6 years, the average duration of psoriasis was 11 (7; 25.8) years, the average duration of psoriatic arthritis was 7 (2; 11.8) years. Among the patients included in the study were 42 (45.7%) men and 50 (54.3%) women. Results. The most common pathology was hypertension with a frequency of 38%, exertional angina – in 5.4% and postinfarct cardiosclerosis – in 2.2%, chronic heart failure – in 6.5% of patients. Cardiovascular pathology combined with diabetes mellitus, dyslipidemia, etc., was observed in 16.3% of patients. Cerebrovascular disorders were detected in 3.3%. Conclusions. A holistic approach to patients with PsA and Ps is recommended – focusing not only on skin or joint symptoms, but also on all aspects of the disease, including comorbidities, can improve the management of the disease and prevent long-term mental and physical impairment. | ||
650 | 4 | |a psoriatic arthritis | |
650 | 4 | |a psoriasis | |
650 | 4 | |a comorbidities | |
650 | 4 | |a clinician's guidelines | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Surgery | |
700 | 0 | |a Liliana Groppa |e verfasserin |4 aut | |
700 | 0 | |a Eugeniu Russu |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Arta Medica |d Association of Surgeons of the Republic of Moldova, 2020 |g 89(2023), 4 |w (DE-627)DOAJ078632528 |x 18101879 |7 nnns |
773 | 1 | 8 | |g volume:89 |g year:2023 |g number:4 |
856 | 4 | 0 | |u https://doi.org/10.5281/zenodo.10429309 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/82ef7dcc2bd0444b92dc14204665084c |z kostenfrei |
856 | 4 | 0 | |u https://artamedica.md/index.php/artamedica/article/view/287 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1810-1852 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1810-1879 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 89 |j 2023 |e 4 |